Krish S. Krishnan, President and CEO, 10% Owner at Krystal Biotech, Inc. (KRYS), sold 50,000 shares at $257.31 ($13.2M) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Open-market sale of $13.2M KRYS by President and CEO, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $257.31 | 483 | $124K | 0.9% |
| 2 | $257.31 | 483 | $124K | 0.9% |
| 3 | $258.38 | 470 | $121K | 0.9% |
| 4 | $258.38 | 470 | $121K | 0.9% |
| 5 | $259.87 | 1,377 | $358K | 2.7% |
| 6 | $259.87 | 1,377 |
| $358K |
| 2.7% |
| 7 | $260.49 | 3,128 | $815K | 6.2% |
| 8 | $260.49 | 3,128 | $815K | 6.2% |
| 9 | $261.41 | 2,962 | $774K | 5.9% |
| 10 | $261.41 | 2,962 | $774K | 5.9% |
| 11 | $262.44 | 2,380 | $625K | 4.7% |
| 12 | $262.44 | 2,380 | $625K | 4.7% |
| 13 | $263.70 | 2,043 | $539K | 4.1% |
| 14 | $263.70 | 2,043 | $539K | 4.1% |
| 15 | $264.85 | 8,798 | $2.3M | 17.7% |
| 16 | $264.85 | 8,798 | $2.3M | 17.7% |
| 17 | $265.59 | 2,439 | $648K | 4.9% |
| 18 | $265.59 | 2,439 | $648K | 4.9% |
| 19 | $266.56 | 920 | $245K | 1.9% |
| 20 | $266.56 | 920 | $245K | 1.9% |
| Total | $263.17 avg | 50,000 | $13.2M | 100% |
| Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |
| KRYS | SELL | 2025-07-11 | $4.0M | — | Filing → |